Liver Failure: New Insights for the Healthcare Professional: 2011 Edition: ScholarlyPaper
ScholarlyEditions, Jan 9, 2012 - Medical - 20 pages
Liver Failure: New Insights for the Healthcare Professional: 2011 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Liver Failure in a compact format.
The editors have built Liver Failure: New Insights for the Healthcare Professional: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Liver Failure in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Liver Failure: New Insights for the Healthcare Professional: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility.
What people are saying - Write a review
Compound heterozygous polymerase gamma gene mutation in a patient with Alpers disease
Antifibrotic therapies will we ever get there?
Oral medications with significant hepatic metabolism at higher risk for hepatic adverse events
Impact of age at diagnosis on clinical features in children with anomalous arrangement of the pancreaticobiliary duct
Salvage effect of E5564 Tolllike receptor 4 antagonist on dgalactosamine and lipopolysaccharideinduced acute liver failure in rats
Reports outline angiology study results from M Inarrairaegui et al
Alginateencapsulated HepG2 cells in a fluidized bed bioreactor maintain function in human liver failure plasma
Keratin variants predispose to acute liver failure and adverse outcome race and ethnic associations
Costeffectiveness of the artificial liver support system MARS in patients with acuteonchronic liver failure
POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders